Lv3
282 积分 2025-04-02 加入
Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration
5天前
已完结
Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC
5天前
已完结
JAB-3312, a Potent Allosteric SHP2 Inhibitor that Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
1个月前
已完结
Making Progress Along the Challenging Road of Drug Development for Patients With EGFR Exon 20 Insertion–Positive Non–Small Cell Lung Cancer
1个月前
已完结
Modulating mental health risk in atopic dermatitis with dupilumab
1个月前
已关闭
Efficacy and Safety of Dupilumab in Patients over 80 Years Old
1个月前
已关闭
Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System
1个月前
已完结
Can a High-Dose of Furmonertinib Effectively Address Unmet Needs in EGFR-Mutated NSCLC with Leptomeningeal Metastases?
1个月前
已关闭
A Response to the Letter to the Editor: Can High-Dose Furmonertinib Effectively Address Unmet Needs in EGFR-Mutated NSCLC With Leptomeningeal Metastases?
2个月前
已关闭
Ribociclib-induced autoimmune-like hepatitis: a case report
2个月前
已完结
皖公网安备34019202002308
